This study was approved by the local ethics committee and was performed in accordance with the ethical standards laid down in the Declaration of Helsinki. Exclusion criteria included subjects under 40 or over 70 years of age, with unrealistic visual outcome expectations or with a profession demanding visual precision (e.g., an architect), psychiatric diseases, stroke, dyslexia, dissatisfaction with progressive glasses, or the need for an IOL power beyond the available diopter range (+5.0 to +34 D). Patients were included if they were between 40 and 70 years old and had bilateral cataracts, preoperative corneal astigmatism of less than 1.0 D, strong motivation for independence from wearing corrective lenses, and who agreed to attend the scheduled follow-up visits. The study included 40 eyes of 20 patients (16 females, 4 males), with a mean age of 56.10☖.8 years (range 48–67 years) undergoing cataract surgery with implantation of the diffractive 1-piece IOL Tecnis ZMB00 in 1 eye and 3 weeks later in the other eye. The aim of the current study was to evaluate binocular visual outcomes, including the analysis of intermediate visual function, with this diffractive multifocal IOL at 3 and 6 months after surgery. To date, the results of 2 reported studies have shown that this type of multifocal IOL is able to provide excellent objective and subjective results, with effective restoration of near and distance visual function. The additive effects of different optical design elements contribute to contrast loss in pseudophakic eyes implanted with different aspheric IOLs (presented at the XXVII Congress of the ESCRS, Barcelona, 2009). Furthermore, chromatic dispersion induced by this relatively new IOL is low and can result in an improvement in contrast sensitivity of up to 12% in comparison with other IOLs made of hydrophobic acrylic materials (e.g., Zhao H, Piers PA, Mainster MA). Specifically, the aspheric surface of this IOL induces a controlled amount of negative spherical aberration that compensates for the positive spherical aberration usually present in the cornea. This IOL is CE-marked and obtained FDA approval in 2010. One relatively new design of multifocal IOL is the 1-piece IOL Tecnis ZMB00 (Abbott Medical Optics), which combines diffractive and aspheric optics. Refractive, diffractive, and hybrid apodized (refractive/diffractive) multifocal IOLs are currently available for clinical use. This can be achieved by implanting specific models of multifocal intraocular lenses (IOLs). The goal of modern cataract surgery is not only to remove the opacified lens, but also to restore visual function at various distances.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |